Company / Working Capital per Share
Fulgent Genetics, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$15.09
FY2025
5-year range
$9.47 / $17.98
FY2021-FY2025
Trend
+59.5%
vs FY2024
Sector context
#29 of 158
Health Care
What the data says
Fulgent Genetics, Inc.'s working capital per share of $15.09 is higher than 82% of companies in the Health Care sector (FY2025). Working Capital per Share returned to growth in FY2025 after 4 years of decline, reaching $15.09.
Based on SEC 10-K filings.
15.09 in FY2025 with a 5-year CAGR of -3.8%. Top quartile in the Health Care sector.
Improved from $14.77 to $15.09 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -5.5%
- 5-Year CAGR
- -3.8%
- 10-Year CAGR
- -
Sector benchmark
-38.3% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 59.5% year-over-year.
- Ranks #29 out of 158 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
- Lowest working capital per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 5.28 (safe zone, above 2.9 threshold)
- Negative profit margin: -15.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.09 | +59.5% |
| FY2024 | $9.47 | -35.9% |
| FY2023 | $14.77 | -17.5% |
| FY2022 | $17.90 | -0.5% |
| FY2021 | $17.98 | -1.8% |
| FY2020 | $18.32 | +897.9% |
| FY2019 | $1.84 | -11.0% |
| FY2018 | $2.06 | +21.8% |
| FY2017 | $1.69 | +31.1% |
| FY2016 | $1.29 | +581.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026